Please use this identifier to cite or link to this item: http://hdl.handle.net/10773/40875
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNikolovski, Aleksandrapt_PT
dc.contributor.authorGamgoum, Larapt_PT
dc.contributor.authorDeol, Arshpreetpt_PT
dc.contributor.authorQuilichini, Sheapt_PT
dc.contributor.authorKazemir, Ethanpt_PT
dc.contributor.authorRhodenizer, Jonathanpt_PT
dc.contributor.authorOliveira, Anapt_PT
dc.contributor.authorBrooks, Dinapt_PT
dc.contributor.authorAlsubheen, Sanaapt_PT
dc.date.accessioned2024-02-26T11:38:10Z-
dc.date.available2024-02-26T11:38:10Z-
dc.date.issued2023-03-02-
dc.identifier.issn0963-8288pt_PT
dc.identifier.urihttp://hdl.handle.net/10773/40875-
dc.description.abstractPurpose: The Hospital Anxiety and Depression Scale (HADS) is used to assess anxiety and depression in individuals with chronic obstructive pulmonary disease (COPD); however, its measurement properties lack critical appraisal. We aimed to summarize and critically appraise the validity, reliability, and responsiveness of the HADS in COPD. Materials and methods: Five electronic databases were searched. The Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) guidelines were used to assess the methodological and evidence quality in the selected studies. Results: Twelve studies assessed the psychometric properties of the HADS-Total and its subscales HADSAnxiety and HADS-Depression in COPD. High-quality evidence supported the structural and criterion validity of the HADS-A, the internal consistency of the HADS-T, HADS-A, and HADS-D with Cronbach’s alpha values of 0.73–0.87, and before–after treatment responsiveness of HADS-T and its subscales (minimal clinically important difference ¼ 1.4–2; effect size ¼ 0.45–1.40). Moderate-quality evidence supported the test–retest reliability of the HADS-A and HADS-D with excellent coefficient values of 0.86–0.90. Conclusions: The HADS-A is recommended for use in individuals with stable COPD. The lack of high-quality evidence on the validity of the HADS-D and HADS-T prevented drawing robust conclusions about their clinical utility in COPD.pt_PT
dc.language.isoengpt_PT
dc.publisherTaylor & Francis Grouppt_PT
dc.rightsrestrictedAccesspt_PT
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectCOPDpt_PT
dc.subjectHADSpt_PT
dc.subjectReliabilitypt_PT
dc.subjectResponsivenesspt_PT
dc.subjectValiditypt_PT
dc.titlePsychometric properties of the Hospital Anxiety and Depression Scale (HADS) in individuals with stable chronic obstructive pulmonary disease (COPD): a systematic reviewpt_PT
dc.typearticlept_PT
dc.description.versionpublishedpt_PT
dc.peerreviewedyespt_PT
degois.publication.titleDisability and Rehabilitationpt_PT
dc.identifier.doi10.1080/09638288.2023.2182918pt_PT
dc.identifier.essn1464-5165pt_PT
Appears in Collections:ESSUA - Artigos
Lab3R - Artigos

Files in This Item:
File Description SizeFormat 
2023_Nikolovski_Psychometric properties.pdf1.12 MBAdobe PDFrestrictedAccess


FacebookTwitterLinkedIn
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.